BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 24.07.2013

Draft Guidance for Industry on Pre-Launch Activities Importation Requests; Availability

The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Pre-Launch Activities Importation Requests (PLAIR)." This draft guidance describes FDA's policy regarding requests for the importation of unapproved finished dosage form drug products by applicants preparing products for market launch based on anticipated approval of a pending new drug application (NDA) or an abbreviated new drug application (ANDA). This draft guidance also applies to biologics licensing applications (BLAs) regulated by the Center for Drug Evaluation and Research. This draft guidance further describes the procedures for making these requests and the criteria that FDA will consider in granting such requests.

Source: Federal Register — Food and Drug AdministrationOpen original release →